Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder

How did Trump-Musk feud impact Tesla stock? Why is China limiting rare earth exports? What caused Dow's recent 300-point surge? How will Senate GOP megabill affect economy? Why is Amazon freezing retail hiring budget? How did Boeing's China delivery pause resolve? What are the implications of Trump's tariff policy?

Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder

benzinga.com/news/health-care/25/06/45789712/exclusive-telomir-pharmaceuticals-lead-drug-shows-promising-signs-in-animal-study-for-rare-prema

Telomir Pharmaceuticals Inc. (NASDAQ:TELO) on Thursday released new preclinical data for its lead candidate, Telomir-1.
The data demonstrated that Telomir-1, administered orally, significantly increases telomere length, reverses body weight and muscle loss, and resets cellular aging…

This story appeared on benzinga.com, 2025-06-05 11:41:39.